Data / Form D filings / Thiogenesis Therapeutics, Corp.
Thiogenesis Therapeutics, Corp.: Form D filings
Thiogenesis Therapeutics, Corp., a biotechnology company in Toronto, Ontario, Canada, filed 5 Form D notices with the SEC between 2021 and 2026. The latest, on June 9, 2026, reports $28,964 sold of a $28,964 offering.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4 KING STREET WEST, SUITE 401, Toronto, Ontario, Canada, M5H 1
- Phone
- (888) 223-9165
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1877778
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | New notice | $28,964 | $28,964 | 0 | Jun 1, 2026 | sec.gov | |
| Aug 8, 2025 | New notice | $125,450 | $125,450 | 0 | Jul 30, 2025 | sec.gov | |
| Dec 20, 2023 | New notice | $252,281 | $252,281 | 1 | Dec 15, 2023 | sec.gov | |
| Nov 25, 2022 | New notice | $218,303 | $218,303 | 3 | Nov 18, 2022 | sec.gov | |
| Aug 11, 2021 | New notice | $252,756 | $252,756 | 2 | Jul 30, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brook G. Riggins | Executive Officer, Director | |
| Patrice Rioux | Executive Officer, Director | |
| W. Hogan Mullally | Director | |
| Kim Tsuchimoto | Director | |
| Christopher Starr | Director |
Every Form D from the week of Jun 8, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Thiogenesis Therapeutics, Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.